C1514892||resistance
C3714514||Plasmodium falciparum infections
C0017395||custom dual indexing
C0017395||Illumina next generation sequencing-technology
C0032529||Genetic polymorphisms
C0032150||P. falciparum
C0030498||parasite's
C0243095||susceptibility
C0003374||antimalarial drugs
C0565935||geographical origin
C1283169||monitoring
C0013203||antimalarial drug resistance
C2732533||multiplex PCR
C0017395||custom designed dual indexing
C3898361||Miseq
C1294197||sequencing
C0752046||SNP
C0024530||malaria
C3714514||infections
C0018387||Guinea-Bissau
C0017256||amplifying
C1294197||sequencing
C1514892||resistance
C0752046||SNPs
C0017337||pfcrt
C0017337||pfmdr1
C0017337||pfdhfr
C0017337||pfdhps
C0017337||pfK13
C0026237||mitochondrial
C0004738||barcode
C0030498||parasite
C0584985||origin
C0752046||SNPs
C0752046||SNP
C0733755||positions
C0752046||SNP
C0013203||artemisinin resistance
C0752046||SNPs
C0017337||pfK13
C0018387||Guinea-Bissau
C0017337||pfmdr1
C0026237||mitochondrial
C0004738||barcodes
C0584985||West African origin
C0030498||parasites
C0025663||method
C0038842||surveillance
C0013203||antimalarial drug resistance